OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
63
Views
11
CrossRef citations to date
0
Altmetric
Original Research
High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis
Geqi Cha1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
, Jianyu Xu1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
, Xiangying Xu1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, HeilongjiangCorrespondence[email protected]
, Bin Li2 Department of Plastic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong
, Shan Lu1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
, Abiyasi Nanding3 Department of Pathology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
, Songliu Hu1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
& Shilong Liu1 Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
show all
Pages 5907-5914
|
Published online: 12 Dec 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.